Cas 158075-62-8,(2R,4R,5R)-2-(3,4-Dimethyl-5-phenyloxazolidin-2-yl) phenyl lithium

158075-62-8

Post Buying Request

Basic information

Product Name: (2R,4R,5R)-2-(3,4-Dimethyl-5-phenyloxazolidin-2-yl) phenyl lithium
Synonyms: (2R,4R,5R)-2-(3,4-Dimethyl-5-phenyloxazolidin-2-yl) phenyl lithium
CAS NO:158075-62-8
Molecular Formula:
Molecular Weight: 259.277
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (2R,4R,5R)-2-(3,4-Dimethyl-5-phenyloxazolidin-2-yl) phenyl lithium(CAS DataBase Reference)
NIST Chemistry Reference: (2R,4R,5R)-2-(3,4-Dimethyl-5-phenyloxazolidin-2-yl) phenyl lithium(158075-62-8)
EPA Substance Registry System: (2R,4R,5R)-2-(3,4-Dimethyl-5-phenyloxazolidin-2-yl) phenyl lithium(158075-62-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 158075-62-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

158075-62-8 Suppliers

Recommended suppliers

158075-62-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 158075-62-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,0,7 and 5 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 158075-62:
(8*1)+(7*5)+(6*8)+(5*0)+(4*7)+(3*5)+(2*6)+(1*2)=148
148 % 10 = 8
So 158075-62-8 is a valid CAS Registry Number.

158075-62-8Upstream product

153581-15-8 (2R,4R,5R)-2-(2-Bromophenyl)-3,4-dimethyl-5-phenyloxazolidine

158075-62-8Downstream Products

158075-62-8Relevant academic research and scientific papers

Method for preparing a benzaldehyde intermediate

-

, (2008/06/13)

A method is provided for preparing a chiral benzaldehyde of the structure STR1 by acylating an anhydride of the structure STR2 with a chiral oxazolidine of the structure STR3 where Q is MgHal or Li, and X, Y and Z are as described herein, to form a keto acid which is reduced and cyclized. The resulting benzaldehyde may be used in making the final anti-thrombotic - anti-vasospastic compounds. Novel intermediates are also provided.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 158075-62-8